Registration summary
ConferenceICVCT
ModeStandard / Physical
ParticipationListener
Registration fee$155.00
Bank charges (5.8%)$8.99
Total payable$163.99
Includes all bank processing charges — the amount above is exactly what will be charged.
Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDG-Aligned Research Themes
ICVCT conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.
01 Innovations in Vaccine Trial Design +
This track focuses on the latest methodologies and innovative approaches in the design of vaccine clinical trials. Emphasis will be placed on adaptive trial designs and their implications for improving trial efficiency and outcomes.
02 Safety Evaluation in Vaccine Development +
This session will explore the critical aspects of safety evaluation in vaccine trials, including methodologies for monitoring adverse events. Participants will discuss best practices for ensuring participant safety and regulatory compliance.
03 Efficacy Assessment of Vaccines +
This track will delve into the various strategies for assessing vaccine efficacy during clinical trials. Discussions will include statistical methods, endpoints, and the role of real-world evidence in efficacy evaluation.
04 Regulatory Affairs in Vaccine Trials +
This session will address the regulatory landscape governing vaccine clinical trials, including the role of agencies such as the FDA and EMA. Experts will discuss the challenges and opportunities in navigating regulatory requirements.
05 Data Management and Analysis in Vaccine Trials +
This track will focus on the importance of data management and statistical analysis in the context of vaccine clinical trials. Topics will include data integrity, analysis techniques, and the use of technology in data collection.
06 Licensing and Market Authorization of Vaccines +
This session will cover the processes involved in obtaining licensing and market authorization for vaccines post-trial. Experts will discuss the implications of regulatory pathways and the importance of compliance.
07 Adverse Events Monitoring in Clinical Trials +
This track will examine the methodologies for monitoring and reporting adverse events in vaccine clinical trials. The importance of transparency and ethical considerations in adverse event management will be highlighted.
08 Ethical Considerations in Vaccine Trials +
This session will explore the ethical implications of conducting vaccine clinical trials, including informed consent and participant rights. Discussions will focus on balancing scientific advancement with ethical responsibilities.
09 Global Perspectives on Vaccine Trials +
This track will provide insights into the global landscape of vaccine clinical trials, highlighting differences in regulatory frameworks and trial designs across regions. Participants will share experiences and best practices from diverse settings.
10 Community Engagement in Vaccine Research +
This session will discuss the importance of community engagement in the design and implementation of vaccine trials. Strategies for building trust and fostering collaboration with communities will be explored.
11 Future Directions in Vaccine Research +
This track will focus on emerging trends and future directions in vaccine research and clinical trials. Topics will include novel vaccine technologies, personalized medicine approaches, and the impact of global health challenges.
